case_images: PMC10272721_01
case_images: 18F-FDG PET/MR image. Compared with before levodopa treatment (A), FDG-SUVR of all ROIs, including cortex (frontal lobe, parietal lobe, temporal lobe, occipital lobe and cingulate gyrus) and subcortex (putamen, caudate nucleus, thalamus and midbrain), increased significantly after 6 months of treatment (B). FL, frontal lobe; PL, parietal lobe; TL, temporal lobe; OL, occipital lobe; CG, cingulate gyrus; Cd, caudate nucleus; P, putamen; Th, thalamus; M, midbrain.
case_images: fneur-14-1184713-g0001.jpg
case_images: PMC10272721_01_fneur-14-1184713-g0001.jpg
case_images: F1
case_images: Head CT scan showed no ventricle enlargement. 18F fluorodeoxyglucose (18F-FDG) PET/MR images showed extensive cortical and subcortical hypometabolic patterns (Figure 1).